AstraZeneca jumps on board
with SCI
SCI’s corporate partner scheme is going from strength
to strength with the addition of AstraZeneca, one of the world’s
top-ranking pharmaceutical companies and a key player in the
UK, where it employs 10,000 people.
As the company has committed to signing up at least ten new
SCI Members at its Avlon site in Bristol, it qualifies for
our Bronze band. This will give the company 10% off subscription
fees, exhibition rates, and advertising in SCI journals and
publications.
AstraZeneca will also gain a much greater online presence,
being able to post free job ads on SCI’s website and
banner ads on C&I’s site — all read by some
of the most influential figures in the industry.
‘We are proud to be associated with SCI, and there are
a lot of benefits for us,’ Sue Tasker (right), Senior
Administrator at AstraZeneca's Avlon site, told SCI Members' News.
‘We will welcome the ease of monitoring our renewals,
discounted subscriptions and spending, and the opportunity
for our banner to appear in SCI media.
‘The discounted conference fees have encouraged increased
membership and it is good to have a point of contact for any
queries.’
SCI’s Membership Development Executive, Beth Galloway,
said: ‘I am looking forward to SCI establishing a closer
relationship between the Bristol & South Western Section
and the AstraZeneca Avlon site with a view to encouraging
good relations between the community, SCI Members and AstraZeneca’s
own goals.’
Noting that AstraZeneca has five other sites around the UK,
and many more internationally, Beth added: ‘We are looking
forward to rolling out the corporate partner scheme to other
sites. It is a great move and benefits Members, and we hope
this is just a first step.’
For more information on our Corporate Partners Scheme contact:
Rosie Baston, Membership Registrar, T: +44 (0)20 7598 1503, F: +44 (0)20 7823
1698, E: rosie.baston[ at]soci.org
|
